Juana de la Torre Arrieta
Development Project Manager
Juana de la Torre Arrieta, with degrees in Molecular Biology and Biochemistry, is part of the Stablepharma science team, working closely with our Chief Development Officer, progressing the development of our lead candidate Td vaccine, SPVX02 into GMP manufacture and clinical trials in 2024.
Juana is based at our R&D facility in Madrid and previously worked for GSK. Her area of expertise is around project delivery, being proactive, addressing and finding solutions to challenges. She has a strong background in biochemistry, molecular biology and immunology and has a global perspective of Life Sciences, having worked in Spain, South America and Ireland.